Global Edition
Global Edition
UK Edition
EU Edition
US Edition

Understand the story, not the spin.

Markets

SELLAS Life Sciences Group, Inc. News

Recent Verilumia coverage about SELLAS Life Sciences Group, Inc. (SLS), including reporting-tone insights and market listing information.

SELLAS Reports Survival Benefit in Phase 3 Leukemia Trial

SELLAS Reports Survival Benefit in Phase 3 Leukemia Trial

SELLAS Life Sciences said its Phase 3 REGAL trial of the experimental cancer vaccine galinpepimut-S met its primary overall-survival endpoint in patients with acute myeloid leukemia, reporting median survival of 24...

Coverage Mix 5 source articles
Left 0% Centre 100% Right 0%
Now playing
0:00 / 0:00